临床儿科杂志 ›› 2020, Vol. 38 ›› Issue (5): 351-.doi: 10.3969/j.issn.1000-3606.2020.05.009

• 遗传学疾病专栏 • 上一篇    下一篇

IDS 基因同义突变致黏多糖贮积症Ⅱ型一家系报告

邓胜勇 1, 高万春 1, 钟敏 1,2, 蒲向阳 1   

  1. 1.重庆市黔江中心医院(重庆 409099);2.重庆医科大学附属儿童医院神经疾病诊治中心 儿童发育 疾病研究教育部重点实验室 儿童发育重大疾病国家国际科技合作基地 儿科学重庆市重点实验室 国家儿童健康与疾病临床医学研究中心(重庆 400014)
  • 出版日期:2020-05-15 发布日期:2020-06-02
  • 通讯作者: 蒲向阳 电子信箱:cqqjpxy@163.com

A family of mucopolysaccharidosis type Ⅱ caused by a synonymous variant in IDS gene

 DENG Shengyong1, GAO Wanchun1, ZHONG Min1,2, PU Xiangyang1   

  1. 1. Qianjiang Central Hospital of Chongqing, Qianjiang, 409099, Chongqing, China; 2. Department of Neurology/Ministry of Education Key Laboratory of Child Development and Disorders/China International Science and Technology Cooperation Base of Child Development and Critical Disorders/Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Chongqing, 400014, China
  • Online:2020-05-15 Published:2020-06-02

摘要: 目的 探讨黏多糖贮积症Ⅱ型(MPSⅡ)的临床表现及基因变异。方法 分析1例MPSⅡ先证者及其家系成 员的临床资料、基因检测及艾杜糖-2-硫酸酯酶活性检测结果。结果 先证者,男,15岁,体格发育障碍、听力下降。影像 学示脑室系统扩大,椎骨、肋骨等骨发育不良。尿黏多糖阳性。IDS的8号外显子同义突变(c.1122C>T)。 先证者及其母 亲的艾杜糖-2-硫酸酯酶活性分别为0、6.96 nmol/(4h·mg)。诊断为MPSⅡ。家系中有6例患者及1例疑似者,全为男性, 除先证者外,还有1例存活,其余4例夭折。 1例疑似者于孕7月余时产前诊断脑积水终止妊娠。检测到5例女性携带者。结 论 先证者经艾杜糖-2-硫酸酯酶活性检测和基因检测确诊为MPSⅡ,发现多名女性致病基因携带者及男性患者。

关键词: 黏多糖贮积症Ⅱ型; 艾杜糖-2-硫酸酯酶; 突变; 基因

Abstract:  Objective To explore clinical features and genetic diagnosis of a family with mucopolysaccharide II (MPS II). Methods Clinical data of the patient and his family members were collected, imaging and urine mucopolysaccharide qualitative tests were performed, DNA of patients and family members was extracted, and genetic analysis was carried out by next generation sequencing and Sanger sequencing. Enzyme activities of iduronate-2-sulfatase were performed for the proband and his mother. Results The proband was a 15 years old male, with physical developmental disorder and hearing loss. Imaging test showed enlarged ventricle system, and vertebrae, ribs and other bone dysplasia. Urine mucopolysaccharide was positive, which lead to preliminary diagnosis of MPS II. In his family, 6 patients and 1 suspected child were all male. In addition to the proband, another patient still survived. One suspected child was diagnosed with hydrocephalus during the prenatal diagnosis at 7th month of pregnancy and terminated, the other four patients were all died. Gene tests found an IDS synonymous mutation (exon 8, C. 1122C > T) in the patient, and another 5 female carriers were identified. The enzyme activities of iduronate-2-sulfataseare were respectively 0 nmol/4hr/mg (the proband) and 6.96 nmol/4hr/mg (mother). Conclusion The proband was diagnosed as MPS II, and several male patients and female carriers of pathogenic variant in the family members were identifies. This provided a basis for genetic counseling.

Key words:  mucopolysaccharide II; idurose-2-sulfatase; variant; gene